Homar, Franc; Lozano, Virginia; Marínez-Gómez, Juan; … - In: Health Economics Review 2 (2012) 16, pp. 1-9
Background: The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative is to administer the individual components of the FDCs separately, thus...